The acquired immune deficiency syndrome has reached pandemic proportions. A
naesthetists should be aware of the implications of dealing with increasing
numbers of both diagnosed and undiagnosed, symptomatic and asymptomatic, h
uman immunodeficiency virus-infected patients in the fields of intensive th
erapy, operating theatre anaesthesia, obstetrics and pain management. With
recent advances, important insights have been gained into the pathogenesis
of human immunodeficiency virus. Molecular techniques allow quantification
of viral burden, and together with CD4 T-lymphocyte count, prognosis and re
sponse to therapy can be evaluated. New drugs and therapeutic regimens have
improved prognosis for those who are infected with the virus and vertical
transmission of infection from mother to infant can be minimised. Should ac
cidental occupational exposure to the virus occur, a prophylactic regimen o
f antiretroviral drugs can be administered in an attempt to prevent subsequ
ent human immunodeficiency virus infection.